150 related articles for article (PubMed ID: 11890223)
1. Clinical aspects of X-linked hypophosphatemic rickets.
Chung WT; Niu DM; Lin CY
Acta Paediatr Taiwan; 2002; 43(1):26-34. PubMed ID: 11890223
[TBL] [Abstract][Full Text] [Related]
2. Effect of dipyridamole on serum and urinary phosphate in X-linked hypophosphatemia.
Seikaly MG; Quigley R; Baum M
Pediatr Nephrol; 2000 Nov; 15(1-2):57-9. PubMed ID: 11095012
[TBL] [Abstract][Full Text] [Related]
3. Parathyroid hormone effects on serum 1,25-dihydroxyvitamin D levels in patients with X-linked hypophosphatemic rickets: evidence for abnormal 25-hydroxyvitamin D-1-hydroxylase activity.
Lyles KW; Drezner MK
J Clin Endocrinol Metab; 1982 Mar; 54(3):638-44. PubMed ID: 6276432
[TBL] [Abstract][Full Text] [Related]
4. 24,25 Dihydroxyvitamin D supplementation corrects hyperparathyroidism and improves skeletal abnormalities in X-linked hypophosphatemic rickets--a clinical research center study.
Carpenter TO; Keller M; Schwartz D; Mitnick M; Smith C; Ellison A; Carey D; Comite F; Horst R; Travers R; Glorieux FH; Gundberg CM; Poole AR; Insogna KL
J Clin Endocrinol Metab; 1996 Jun; 81(6):2381-8. PubMed ID: 8964881
[TBL] [Abstract][Full Text] [Related]
5. The concurrence of hypoparathyroidism provides new insights to the pathophysiology of X-linked hypophosphatemic rickets.
Lyles KW; Burkes EJ; McNamara CR; Harrelson JM; Pickett JP; Drezner MK
J Clin Endocrinol Metab; 1985 Apr; 60(4):711-7. PubMed ID: 4038714
[TBL] [Abstract][Full Text] [Related]
6. X-linked hypophosphatemic rickets: a study (with literature review) of linear growth response to calcitriol and phosphate therapy.
Petersen DJ; Boniface AM; Schranck FW; Rupich RC; Whyte MP
J Bone Miner Res; 1992 Jun; 7(6):583-97. PubMed ID: 1414477
[TBL] [Abstract][Full Text] [Related]
7. Decreased concentration of 1,25-dihydroxyvitamin D3 receptors in peripheral mononuclear cells of patients with X-linked hypophosphatemic rickets: effect of phosphate supplementation.
Nakajima S; Yamaoka K; Yamamoto T; Okada S; Tanaka H; Seino Y
Bone Miner; 1990 Sep; 10(3):201-9. PubMed ID: 2171704
[TBL] [Abstract][Full Text] [Related]
8. Long-term influence of calcitriol (1,25-dihydroxyvitamin D) and supplemental phosphate in X-linked hypophosphatemic rickets.
Chesney RW; Mazess RB; Rose P; Hamstra AJ; DeLuca HF; Breed AL
Pediatrics; 1983 Apr; 71(4):559-67. PubMed ID: 6300745
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone sensitivity in familial X-linked hypophosphatemic rickets.
McElduff A; Posen S
J Clin Endocrinol Metab; 1989 Aug; 69(2):386-9. PubMed ID: 2753981
[TBL] [Abstract][Full Text] [Related]
10. Nocturnal hyperparathyroidism: a frequent feature of X-linked hypophosphatemia.
Carpenter TO; Mitnick MA; Ellison A; Smith C; Insogna KL
J Clin Endocrinol Metab; 1994 Jun; 78(6):1378-83. PubMed ID: 8200940
[TBL] [Abstract][Full Text] [Related]
11. X-linked hypophosphatemia: a clinical, biochemical, and histopathologic assessment of morbidity in adults.
Reid IR; Hardy DC; Murphy WA; Teitelbaum SL; Bergfeld MA; Whyte MP
Medicine (Baltimore); 1989 Nov; 68(6):336-52. PubMed ID: 2811660
[TBL] [Abstract][Full Text] [Related]
12. The effect of recombinant human growth hormone in children with X-linked hypophosphatemia.
Seikaly MG; Brown R; Baum M
Pediatrics; 1997 Nov; 100(5):879-84. PubMed ID: 9346990
[TBL] [Abstract][Full Text] [Related]
13. Nature of defect responsible for familial vitamin D-resistant rickets (VDRR) based on radioimmunoassay for parathyroid hormone (PTH).
Roof BS; Piel CF; Gordan GS
Trans Assoc Am Physicians; 1972; 85():172-80. PubMed ID: 4349621
[No Abstract] [Full Text] [Related]
14. A prospective trial of phosphate and 1,25-dihydroxyvitamin D3 therapy in symptomatic adults with X-linked hypophosphatemic rickets.
Sullivan W; Carpenter T; Glorieux F; Travers R; Insogna K
J Clin Endocrinol Metab; 1992 Sep; 75(3):879-85. PubMed ID: 1517380
[TBL] [Abstract][Full Text] [Related]
15. Effect of single oral phosphate loading on vitamin D metabolites in normal subjects and in X-linked hypophosphatemic rickets.
Yamaoka K; Tanaka H; Kurose H; Shima M; Ozono K; Nakajima S; Seino Y
Bone Miner; 1989 Sep; 7(2):159-69. PubMed ID: 2804451
[TBL] [Abstract][Full Text] [Related]
16. Effects of parathyroid hormone and 1,25-dihydroxyvitamin D3 on tubular handling of phosphate in hypophosphatemic rickets.
Alon U; Chan JC
J Clin Endocrinol Metab; 1984 Apr; 58(4):671-5. PubMed ID: 6546575
[TBL] [Abstract][Full Text] [Related]
17. Serum 1,25-dihydroxyvitamin D levels in subjects with X-linked hypophosphatemic rickets and osteomalacia.
Lyles KW; Clark AG; Drezner MK
Calcif Tissue Int; 1982 Mar; 34(2):125-30. PubMed ID: 6282408
[TBL] [Abstract][Full Text] [Related]
18. Effects of therapy in X-linked hypophosphatemic rickets.
Verge CF; Lam A; Simpson JM; Cowell CT; Howard NJ; Silink M
N Engl J Med; 1991 Dec; 325(26):1843-8. PubMed ID: 1660098
[TBL] [Abstract][Full Text] [Related]
19. Exaggerated phosphaturic response to circulating parathyroid hormone in patients with familial X-linked hypophosphatemic rickets.
Short E; Morris RC; Sebastian A; Spencer M
J Clin Invest; 1976 Jul; 58(1):152-63. PubMed ID: 180058
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D metabolism in hypophosphatemic vitamin D-resistant rickets.
Seino Y; Shimotsuji T; Ishida M; Ishii T; Yamaoka K; Yabuuchi H
Contrib Nephrol; 1980; 22():101-6. PubMed ID: 6249540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]